103 related articles for article (PubMed ID: 9611046)
1. Pleurodesis with recombinant tumour necrosis factor in gynaecological neoplasms.
Rauthe G; Sistermanns J
Eur J Gynaecol Oncol; 1998; 19(2):108-12. PubMed ID: 9611046
[TBL] [Abstract][Full Text] [Related]
2. Recombinant tumour necrosis factor in the local therapy of malignant pleural effusion.
Rauthe G; Sistermanns J
Eur J Cancer; 1997 Feb; 33(2):226-31. PubMed ID: 9135493
[TBL] [Abstract][Full Text] [Related]
3. Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion.
Ibrahim IM; Dokhan AL; El-Sessy AA; Eltaweel MF
J Cardiothorac Surg; 2015 May; 10():64. PubMed ID: 25947235
[TBL] [Abstract][Full Text] [Related]
4. Talc pleurodesis improves survival of patients with malignant pleural effusions: case-control study.
Korsic M; Badovinac S; Cucevic B; Janevski Z
Wien Klin Wochenschr; 2015 Dec; 127(23-24):963-9. PubMed ID: 25860847
[TBL] [Abstract][Full Text] [Related]
5. Success rate of medical thoracoscopy and talc pleurodesis in malignant pleurisy: A single-centre experience.
Leemans J; Dooms C; Ninane V; Yserbyt J
Respirology; 2018 Jun; 23(6):613-617. PubMed ID: 29320805
[TBL] [Abstract][Full Text] [Related]
6. Rapid pleurodesis in symptomatic malignant pleural effusion.
Yildirim E; Dural K; Yazkan R; Zengin N; Yildirim D; Gunal N; Sakinci U
Eur J Cardiothorac Surg; 2005 Jan; 27(1):19-22. PubMed ID: 15621465
[TBL] [Abstract][Full Text] [Related]
7. A national survey of oncologist and chest physicians' attitudes towards empirical anti-oestrogen therapy, early pleurodesis and preference of sclerosing agent in malignant breast and ovarian pleural disease.
Medford AR; Maskell NA
Palliat Med; 2005 Jul; 19(5):430-1. PubMed ID: 16111068
[No Abstract] [Full Text] [Related]
8. Analysis of Quality of Life after Pleurodesis in Patients with Malignant Pleural Effusion.
Terra RM; Costa PB; Dela Vega AJM; Araujo PHXN; Teixeira LR; Pêgo-Fernandes PM
Respiration; 2019; 98(6):467-472. PubMed ID: 31694026
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effectiveness of some pleural sclerosing agents used for control of effusions in malignant pleural mesothelioma: a review of 117 cases.
Senyiğit A; Bayram H; Babayiğit C; Topçu F; Balci AE; Satici O
Respiration; 2000; 67(6):623-9. PubMed ID: 11124644
[TBL] [Abstract][Full Text] [Related]
10. Use of small-bore vs large-bore chest tubes for treatment of malignant pleural effusions.
Parulekar W; Di Primio G; Matzinger F; Dennie C; Bociek G
Chest; 2001 Jul; 120(1):19-25. PubMed ID: 11451810
[TBL] [Abstract][Full Text] [Related]
11. [Treatment strategies in malignant pleural effusion of breast carcinoma].
Wolters U; Türler A
Zentralbl Chir; 1998; 123 Suppl 5():128-9. PubMed ID: 10063596
[TBL] [Abstract][Full Text] [Related]
12. Survivin is a negative prognostic factor in malignant pleural effusion.
Arellano-Orden E; Romero-Romero B; Sánchez-López V; Martín-Juan J; Rodríguez-Panadero F; Otero-Candelera R
Eur J Clin Invest; 2018 Apr; 48(4):. PubMed ID: 29359509
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of erythromycin as sclerosing agent in patients with recurrent malignant pleural effusion.
Balassoulis G; Sichletidis L; Spyratos D; Chloros D; Zarogoulidis K; Kontakiotis T; Bagalas V; Porpodis K; Manika K; Patakas D
Am J Clin Oncol; 2008 Aug; 31(4):384-9. PubMed ID: 18845999
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions.
Cardillo G; Facciolo F; Carbone L; Regal M; Corzani F; Ricci A; Di Martino M; Martelli M
Eur J Cardiothorac Surg; 2002 Feb; 21(2):302-5; discussion 305-6. PubMed ID: 11825740
[TBL] [Abstract][Full Text] [Related]
15. [Talc pleurodesis in recurrent malignant pleural effusion--a prospective follow-up study].
Walter M; Türler A; Schmitz-Rixen T
Zentralbl Chir; 1996; 121(3):216-22. PubMed ID: 8867348
[TBL] [Abstract][Full Text] [Related]
16. Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions.
Kishi K; Homma S; Sakamoto S; Kawabata M; Tsuboi E; Nakata K; Yoshimura K
Eur Respir J; 2004 Aug; 24(2):263-6. PubMed ID: 15332395
[TBL] [Abstract][Full Text] [Related]
17. [Distilled water pleurodesis for two breast cancer patients suffering from carcinomatous pleurisy].
Fujishima M; Nakayama T; Tatsuta M; Yamamoto K; Kishi K; Takemoto H; Kishimoto T; Shimizu J; Imamura H; Fukunaga M; Masutani S; Kawasaki T; Furukawa H
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1755-7. PubMed ID: 15553705
[TBL] [Abstract][Full Text] [Related]
18. Talc pleurodesis for the management of malignant pleural effusions in Japan.
Inoue T; Ishida A; Nakamura M; Nishine H; Mineshita M; Miyazawa T
Intern Med; 2013; 52(11):1173-6. PubMed ID: 23728550
[TBL] [Abstract][Full Text] [Related]
19. Malignant Pleural Effusion: Still a Long Way to Go.
Meriggi F
Rev Recent Clin Trials; 2019; 14(1):24-30. PubMed ID: 30514193
[TBL] [Abstract][Full Text] [Related]
20. Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival.
Lumachi F; Mazza F; Ermani M; Chiara GB; Basso SM
Anticancer Res; 2012 Nov; 32(11):5071-4. PubMed ID: 23155281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
